Company intelligence / Profile preview
Probiomed
Mexico City, CDMX, Mexicoprobiomed.com.mx ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Probiomed is a leading Mexican biopharmaceutical company with over five decades of experience in the research, development, manufacturing, and commercialization of generic pharmaceuticals and high-tech biosimilars. Its portfolio covers a broad range of therapeutic areas including autoimmune disease, cancer, metabolic disease, nephrology/renal failure among others. The company has an international footprint with exports to Latin America and beyond. In May 2022 it was acquired by Sanfer to strengthen its biotechnology platform.
- Therapeutic areas
- Metabolic DisordersNeurologyHematologyOncologyImmunology
- Modalities
- Small molecule (generics)Recombinant protein (biosimilars)Monoclonal antibody (biosimilars)Fusion protein (biosimilars)Vaccine (recombinant vaccines)
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Sanfer Group (parent company; future technology transfer/commercial agreements expected as per acquisition announcement)
Beyond the preview
Go deeper on Probiomed.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Probiomed.